Combined Modality Therapy of Esophageal Cancer

Authors:
Rosalyn A. JuergensFrom The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

Search for other papers by Rosalyn A. Juergens in
Current site
Google Scholar
PubMedClose
 MD
and
Arlene ForastiereFrom The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

Search for other papers by Arlene Forastiere in
Current site
Google Scholar
PubMedClose
 MD
Editor:
Kerrin G. RobinsonMedical/Scientific Editor, Journal of the National Comprehensive Cancer Network

Search for other papers by Kerrin G. Robinson in
Current site
Google Scholar
PubMedClose
 MA
Volume/Issue:
Volume 6: Issue 9
Online Publication Date:
Oct 2008
DOI:
https://doi.org/10.6004/jnccn.2008.0063
Full access

Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multimodality approaches to the management of esophageal cancer.

Correspondence: Rosalyn A. Juergens, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Harry and Jeanette Weinberg Building, 401 North Broadway, Baltimore, MD 21231-2410. E-mail: rjuergens@jhmi.edu

Disclosure: Kerrin G. Robinson, MA, has disclosed no relevant financial relationships.

  • Collapse
  • Expand
  • 1.

    Jemal A, Siegel R, Ward E et al.. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.

  • 2.

    Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.

  • 3.

    van Vliet EP, Heijenbrok-Kal MH, Hunink MG et al.. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008;98:547–557.

  • 4.

    Kaushik N, Khalid A, Brody D et al.. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. Ann Thorac Surg 2007;83:2000–2002.

    • Search Google Scholar
    • Export Citation
  • 5.

    Medical Research Counsil Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727–1733.

    • Search Google Scholar
    • Export Citation
  • 6.

    Burmeister BH, Smithers BM, Gebski V et al.. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659–668.

    • Search Google Scholar
    • Export Citation
  • 7.

    Kelsen DP, Ginsberg R, Pajak TF et al.. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979–1984.

    • Search Google Scholar
    • Export Citation
  • 8.

    Herskovic A, Martz K, al-Sarraf M et al.. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593–1598.

    • Search Google Scholar
    • Export Citation
  • 9.

    Cooper JS, Guo MD, Herskovic A et al.. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623–1627.

    • Search Google Scholar
    • Export Citation
  • 10.

    Minsky BD, Pajak TF, Ginsberg RJ et al.. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167–1174.

    • Search Google Scholar
    • Export Citation
  • 11.

    Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2006;CD002092.

    • Search Google Scholar
    • Export Citation
  • 12.

    Chiu PW, Chan AC, Leung SF et al.. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005;9:794–802.

    • Search Google Scholar
    • Export Citation
  • 13.

    Arnott SJ, Duncan W, Kerr GR et al.. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 1992;24:108–113.

    • Search Google Scholar
    • Export Citation
  • 14.

    Gignoux M, Roussel A, Paillot B et al.. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 1987;11:426–432.

    • Search Google Scholar
    • Export Citation
  • 15.

    Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690–692.

  • 16.

    Nygaard K, Hagen S, Hansen HS et al.. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104–1109; discussion 1110.

    • Search Google Scholar
    • Export Citation
  • 17.

    Wang M, Gu XZ, Yin WB et al.. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325–327.

    • Search Google Scholar
    • Export Citation
  • 18.

    Arnott SJ, Duncan W, Gignoux M et al.. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2005;CD001799.

  • 19.

    Allum WH, Fogarty PJ, Stenning SP, Langley RE. Long term results of the MRC OEO2 randomized trial of surgery with or without pre-operative chemotherapy in resectable esophageal cancer. 2008 Gastrointestinal Cancers Symposium; January 25–27, 2008; Orlando, Florida. Abstract 9.

    • Search Google Scholar
    • Export Citation
  • 20.

    Cunningham D, Allum WH, Stenning SP et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.

    • Search Google Scholar
    • Export Citation
  • 21.

    Malthaner RA, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006;CD001556.

    • Search Google Scholar
    • Export Citation
  • 22.

    Gebski V, Burmeister B, Smithers BM et al.. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226–234.

    • Search Google Scholar
    • Export Citation
  • 23.

    Thirion PG, Michiels S, Le Maitre A et al.. Individual patient databased meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma [abstract]. J Clin Oncol 2007;25(Suppl 1):Abstract 4512.

    • Search Google Scholar
    • Export Citation
  • 24.

    Bosset JF, Gignoux M, Triboulet JP et al.. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161–167.

    • Search Google Scholar
    • Export Citation
  • 25.

    Le Prise E, Etienne PL, Meunier B et al.. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779–1784.

    • Search Google Scholar
    • Export Citation
  • 26.

    Lee JL, Park SI, Kim SB et al.. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947–954.

    • Search Google Scholar
    • Export Citation
  • 27.

    Tepper J, Krasna MJ, Niedzwiecki D et al.. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26:1086–1092.

    • Search Google Scholar
    • Export Citation
  • 28.

    Urba SG, Orringer MB, Turrisi A et al.. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305–313.

    • Search Google Scholar
    • Export Citation
  • 29.

    Walsh TN, Noonan N, Hollywood D et al.. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–467.

    • Search Google Scholar
    • Export Citation
  • 30.

    Fiorica F, Di Bona D, Schepis F et al.. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925–930.

    • Search Google Scholar
    • Export Citation
  • 31.

    Doty JR, Salazar JD, Forastiere AA et al.. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg 2002;74:227–131; discussion 131.

    • Search Google Scholar
    • Export Citation
  • 32.

    Bailey SH, Bull DA, Harpole DH et al.. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003;75:217–222; discussion 222.

    • Search Google Scholar
    • Export Citation
  • 33.

    Stahl M, Walz MK, Stuschke M et al.. Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: first results of a randomized phase III trial [abstract]. J Clin Oncol 2007:25(Suppl 1):Abstract 4511.

    • Search Google Scholar
    • Export Citation
  • 34.

    Stahl M, Stuschke M, Lehmann N et al.. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:2310–2317.

    • Search Google Scholar
    • Export Citation
  • 35.

    Crehange G, Maingon P, Peignaux K et al.. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 2007;25:4895–4901.

    • Search Google Scholar
    • Export Citation
  • 36.

    Rizk NP, Seshan VE, Bains MS et al.. Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus. J Thorac Oncol 2007;2:1117–1123.

    • Search Google Scholar
    • Export Citation
  • 37.

    Rizk NP, Venkatraman E, Bains MS et al.. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007;25:507–512.

    • Search Google Scholar
    • Export Citation
  • 38.

    Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994;21:474–482.

    • Search Google Scholar
    • Export Citation
  • 39.

    Swisher SG, Maish M, Erasmus JJ et al.. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:1152–1160; discussion 1160.

    • Search Google Scholar
    • Export Citation
  • 40.

    Erasmus JJ, Munden RF, Truong MT et al.. Preoperative chemoradiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 2006;1:478–486.

    • Search Google Scholar
    • Export Citation
  • 41.

    Lordick F, Ott K, Krause BJ et al.. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007;8:797–805.

    • Search Google Scholar
    • Export Citation
  • 42.

    Ajani JA, Walsh G, Komaki R et al.. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 2004;100:2347–2354.

    • Search Google Scholar
    • Export Citation
  • 43.

    Khushalani NI, Leichman CG, Proulx G et al.. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 2002;20:2844–2850.

    • Search Google Scholar
    • Export Citation
  • 44.

    Kleinberg L, Powell ME, Forastiere A et al.. E1201: an Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus [abstract]. J Clin Oncol 2007;25(Suppl 1): Abstract 4533.

    • Search Google Scholar
    • Export Citation
  • 45.

    Urba SG, Orringer MB, Ianettonni M et al.. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer 2003;98:2177–2183.

    • Search Google Scholar
    • Export Citation
  • 46.

    Simon G, Sharma A, Li X et al.. Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer. J Clin Oncol 2007;25:2741–2746.

    • Search Google Scholar
    • Export Citation
  • 47.

    Joshi MB, Shirota Y, Danenberg KD et al.. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 2005;11:2215–2221.

    • Search Google Scholar
    • Export Citation
  • 48.

    Izzo JG, Correa AM, Wu TT et al.. Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther 2006;5:2844–2850.

    • Search Google Scholar
    • Export Citation
  • 49.

    RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas. Clin Adv Hematol Oncol 2007;5:79–81.

    • Search Google Scholar
    • Export Citation
  • 50.

    Shah MA, Ramanathan RK, Ilson DH et al.. Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol 2006;24:5201–5206.

    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2008 by the National Comprehensive Cancer Network
Page Numbers:
11
Article Category:
Research Article
Received:
24 Apr 2008
Accepted:
28 Jun 2008
Print Publication Date:
01 Oct 2008
Online Publication Date:
Oct 2008
Keywords:
Neoadjuvant; esophageal cancer; chemotherapy; chemoradiotherapy
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 347 117 16
PDF Downloads 236 95 13
EPUB Downloads 0 0 0